Volume 194 - Issue 9
Scurvy and stroke: is there an association?
Authors: Felicity J Rose and Jonathan P Whitehead
Med J Aust 2011; 194 (9): 486. || doi: 10.5694/j.1326-5377.2011.tb03070.x
Published online: 2 May 2011
Published online: 2 May 2011
To the Editor: We read with interest the recent letter by He and colleagues.1 The authors described a case of ischaemic stroke in a patient with scurvy and considered whether there was a connection between the two conditions. They referred to evidence that vitamin C deficiency may be a risk factor for cerebrovascular disease, but acknowledged that a direct causal link is unlikely to be established.
We propose adiponectin as the causal link between vitamin C deficiency and stroke. Adiponectin is an adipokine, secreted in multimers by adipose tissue, with insulin-sensitising, antiatherogenic and cardioprotective properties.2 A decrease in adiponectin levels — particularly the more biologically active, high molecular weight (HMW) multimers — is implicated in a number of disease states, such as obesity, type 2 diabetes, heart disease and some cancers. Adiponectin has also been reported to have cerebroprotective properties,3 and there is some evidence that levels may be reduced in patients with cerebrovascular disease.4
A recent study demonstrated that vitamin C supplementation increases the proportion of HMW adiponectin secreted from human adipocytes.5 Vitamin C levels are lower in obese and diabetic patients, and the patient reported by He et al had also been recently diagnosed with type 2 diabetes.
While scurvy is admittedly rare, He and colleagues noted that subclinical vitamin C deficiency is not uncommon in the general population (about 10%). We suggest that it would be worthwhile to assay plasma vitamin C levels and total and HMW adiponectin levels in patients presenting with cerebrovascular events, and to undertake prospective studies to determine whether vitamin C supplementation improves patients’ adiponectin levels. Increased HMW adiponectin levels could be explained, at least in part, by the role of vitamin C in the multimerisation of adiponectin.
Adiponectin levels are also reduced in other vascular conditions, such as ischaemic heart disease and peripheral vascular disease.4 As plasma vitamin C levels of patients with these diseases are also reduced, it is tempting to posit that vitamin C supplementation could have a role as a treatment, or even a prophylactic, in populations at risk of a range of adiponectin-related vascular diseases.
References
- He EY, Wang LW, Kiernan MC. Scurvy and stroke: is there an association? Med J Aust 2010; 193: 555-556. 0_CBBFIGII
- Whitehead JP, Richards AA, Hickman IJ, et al. Adiponectin — a key adipokine in the metabolic syndrome. Diabetes Obes Metab 2006; 8: 264-280. 0_CBBCCGGF
- Nishimura M, Izumiya Y, Higuchi A, et al. Adiponectin prevents cerebral ischemic injury through endothelial nitric oxide synthase dependent mechanisms. Circulation 2008; 117: 216-223. 0_pgfId-2308939
- Szmitko PE, Teoh H, Stewart DJ, Verma S. Adiponectin and cardiovascular disease: state of the art? Am J Physiol Heart Circ Physiol 2007; 292: H1655-H1663. 0_CBBCBGCA
- Rose FJ, Webster J, Barry JB, et al. Synergistic effects of ascorbic acid and thiazolidinedione on secretion of high molecular weight adiponectin from human adipocytes. Diabetes Obes Metab 2010; 12: 1084-1089. 0_CBBFEJDB
When ‘Liver Enzymes’ Are Not Hepatic: Late-Onset Pompe Disease
Shauna Madigan, Georgina England, Wayne Rankin
Primary Hyperparathyroidism in Adults: Recent Developments in Diagnosis and Management
Elizabeth Wootton, Sunita M. C. De Sousa, Richard L. Prince, Donald S. A. McLeod, David A. Pattison, Mathis Grossmann
Severe Hypoglycaemia Secondary to Chronic Opioid-Induced Hypothalamic–Pituitary–Adrenal Axis Suppression: An Under-Recognised Phenomenon
Michael Do, Annabelle Hayes, Malgorzata Brzozowska
Rethinking diabetes care for Indigenous Australians: the need for Indigenous‐codesigned and led diabetes models of care
Natalie Nanayakkara, Sharon Atkinson‐Briggs, Alicia J Jenkins, Neale D Cohen
The first Australian evidence‐based guidelines on male infertility
Darren J Katz, Liza O’Donnell, Robert I McLachlan, Tim J Moss, Clare V Boothroyd, Veena Jayadev, Sarah R Catford